黄连素联合利多卡因锡类散保留灌肠治疗溃疡性结肠炎54例临床观察

Clinical Observation of Berberine plus Lidocaine and Xileisan Powder Used in Retention for Ulcerative Colitis of 54 Cases

为探讨疗效好、副作用少治疗溃疡性结肠炎的方法，采用黄连素配合利多卡因、锡类散保留灌肠治疗溃疡性结肠炎54例。结果显示，治愈率75．9％，有效率16．5％，无效率7．4％，明显优于对照组，未见明显副作用。结果表明，该法治疗溃疡性结肠炎疗效确切，缩短疗程，无副作用，价格低廉。

For the objective of probing the therapy for ulcerative colitis（UC） ,which has better therapeutic effects and less adverse reaction,author adopted berberine plus lidocaine and Xileisan powder in the enema for UC of 54 cases,as treatment group. As results,in treatment group curative rate,effective rate and noneffective rate were 75.9 %, 16.5 % and 7.4 %, respectively. These results were significantly superior to controlled group and no distinct adverse reaction was found. Thus in above therapy therapeutic effects is certain,treatment course is shorter, side action is less and cost is lower.